A phase I study of the safety and immunogenicity of a West Nile virus recombinant DNA plasmid vaccine, VRC-WNVDNA017-00 VP, in healthy adult volunteers

Trial Profile

A phase I study of the safety and immunogenicity of a West Nile virus recombinant DNA plasmid vaccine, VRC-WNVDNA017-00 VP, in healthy adult volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs West Nile virus vaccine (Primary)
  • Indications West Nile virus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top